Cargando…
An orally administered drug prevents selection for antibiotic-resistant bacteria in the gut during daptomycin therapy
BACKGROUND AND OBJECTIVES: Previously, we showed proof-of-concept in a mouse model that oral administration of cholestyramine prevented enrichment of daptomycin-resistant Enterococcus faecium in the gastrointestinal (GI) tract during daptomycin therapy. Cholestyramine binds daptomycin in the gut, wh...
Autores principales: | Morley, Valerie J, Sim, Derek G, Penkevich, Aline, Woods, Robert J, Read, Andrew F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472784/ https://www.ncbi.nlm.nih.gov/pubmed/36118914 http://dx.doi.org/10.1093/emph/eoac035 |
Ejemplares similares
-
An adjunctive therapy administered with an antibiotic prevents enrichment of antibiotic-resistant clones of a colonizing opportunistic pathogen
por: Morley, Valerie J, et al.
Publicado: (2020) -
Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium
por: Kinnear, Clare L., et al.
Publicado: (2020) -
Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria
por: Blaskovich, Mark A. T., et al.
Publicado: (2018) -
Multifunctional Pharmaceutical Effects of the Antibiotic Daptomycin
por: Ye, Yang, et al.
Publicado: (2019) -
Bystander Selection for Antimicrobial Resistance: Implications for Patient Health
por: Morley, Valerie J., et al.
Publicado: (2019)